Skip to content
Sign in
Artwork for Treating Blood Cancers
Health & FitnessMedicineEducationScienceNatural Sciences

Treating Blood Cancers

Blood Cancer United

Podcast series for professionals by Blood Cancer United

Play
Open in
  • 20 episodes
  • fortnightly
  • Avg 36 min
  • English

Episodes 20

NewestOldestLongest
All20Unplayed20In progress0Played0
  • Friday · 37 min

    Moving Forward: Physical Therapy in Cancer Survivorship

    Stefanie Losensky, PT, DPT, CLT, Brigham and Women’s Faulkner Hospital, Jamaica Plain, MA Recorded on October 8, 2026 Stefanie Losensky, PT, DPT, CLT Board-Certified Clinical Specialist in Oncologic Physical Therapy, Department of Rehabilitation Brigham and Women’s Faulkner Hospital Jamaica Plain, MA Join Stefanie Losensky, PT, DPT, CLT from the Department of Rehabilitation at Brigham and Women’s Faulkner Hospital for an insightful discussion on the role of physical therapy in cancer survivorship. Stefanie explores common physical challenges and examines the timing and integration of physical therapy throughout the cancer care continuum. She discusses evidence-based interventions that can improve function, mobility, and quality of life, while also addressing insurance coverage, access to rehabilitation services, and practical educational resources to support healthcare professionals. Mentioned on this episode: Cancer Rehab Austin Video Library APTA Find a Specialist Revital Cancer Rehab American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control Effects of Exercise on Health-Related Outcomes in those with Cancer Oncology EDGE Taskforce Annotated Bibliography Exercise is medicine in oncology: Engaging Clinicians to help patients move through cancer Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

  • October 13 · 32 min

    BPDCN: Diagnosis to Emerging Therapies

    Hannah Levavi, MD, Tisch Cancer Center at Mount Sinai Hospital, New York, NY Recorded on September 24, 2026 Hannah Levavi, MD Assistant Professor of Medicine, Division of Hematology & Medical Oncology Tisch Cancer Center at Mount Sinai Hospital New York, NY In this episode, join Dr. Hannah Levavi from the Tisch Cancer Center at Mount Sinai Hospital, as she explores the evolving landscape of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Dr. Levavi reviews the clinical presentation and key diagnostic features of BPDCN, along with current first-line treatment approaches. She also examines the role of stem cell transplantation and discusses emerging therapies, including targeted agents and CAR T-cell therapy. The episode concludes with a look at ongoing research and future directions aimed at improving outcomes for patients with BPDCN. Tune in for this informative discussion on this rare hematologic malignancy! Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

  • September 15 · 35 min

    Caring for LGBTQI+ Patients with Cancer

    Jason Domogauer, MD, PhD, NYU Perlmutter Cancer Center, New York, NY Recorded on August 27, 2026 Jason Domogauer, MD, PhD Director, LGBTQ+ Cancer Care and Research Program, Perlmutter Cancer Center Assistant Director, Community Outreach and Engagement, Perlmutter Cancer Center Director, Community Outreach and Engagement, Department of Radiation Oncology; Assistant Professor, Department of Radiation Oncology NYU Langone Health New York, NY Join us for an insightful conversation with Dr. Jason Domogauer from NYU Perlmutter Cancer Center as we explore the unique challenges and disparities faced by LGBTQI+ individuals across the cancer continuum. Dr. Domogauer discusses the psychosocial, clinical, and communication needs of LGBTQI+ patients with cancer, as well as strategies for delivering inclusive, affirming care. He also shares approaches to fostering welcoming healthcare environments, and highlights resources for both clinicians and patients. Tune in to this thoughtful discussion on advancing equitable, patient-centered cancer care. Mentioned on this episode: Cancer Network Fenway Institute Kone Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

  • August 28 · 34 min

    Strengthening Bereavement Care in Oncology

    Ramy Sedhom, MD, FASCO, University of Pennsylvania, Plainsboro, NJ Recorded on August 13, 2026 Ramy Sedhom, MD, FASCO Associate Professor, Clinical Medicine, Division of Hematology/Oncology Director, Program in Geriatric Oncology & Supportive Care Innovation and the Center for Cancer and Aging at the Penn Center for Cancer Care Innovation University of Pennsylvania Plainsboro, NJ In this episode, Dr. Ramy Sedhom from the University of Pennsylvania explores the role of bereavement support in oncology care. He discusses how clinicians can support patients’ families after a loss, recognize when grief may require additional intervention, and incorporate meaningful bereavement practices into routine care. The conversation also examines the impact of patient loss on healthcare professionals and offers practical strategies to reduce clinician moral distress and burnout. Tune in today for this thoughtful conversation! Mentioned on this episode: The Journal of Palliative Medicine: Top Ten Tips on Bereavement Care Man’s Search for Meaning by Viktor E. Frankl It’s OK That You’re Not OK by Megan Devine Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

  • July 10 · 36 min

    Waldenström macroglobulinemia: What to Know in Practice

    Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN Recorded on June 23, 2026 Stephen Ansell, MD, PhD Division Chair, Hematology Mayo Clinic Rochester, MN Join Dr. Stephen Ansell from Mayo Clinic for an in-depth discussion on Waldenström macroglobulinemia, focusing on the latest advances in diagnosis, treatment, and management. This episode explores clinical features, the importance of molecular markers in guiding diagnosis and treatment decisions, and current indications for initiating therapy. The discussion also addresses the management of IgM-related complications, emerging therapeutic approaches, and future directions in care. Listen to this exciting and informative episode today! Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

  • June 25 · 34 min

    Mastocytosis: What Clinicians Need to Know

    Marina Kremyanskaya, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY Recorded on June 2, 2026 Marina Kremyanskaya, MD, PhD Associate Professor Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York, NY Join Dr. Marina Kremyanskaya from the Icahn School of Medicine at Mount Sinai in this expert discussion on mastocytosis, including an overview of the disease, key signs and symptoms, and current diagnostic criteria with a focus on relevant genetic mutations. She discusses recently approved therapies, emerging treatment approaches, and ongoing clinical trials that are shaping future treatment. The episode also covers approaches to managing complications, addressing treatment-related side effects, and delivering patient-centered care. Don’t miss this informative episode! Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

  • June 15 · 42 min

    CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support

    Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL Recorded on May 28, 2026 Tara Gregory, MD President Colorado Blood Cancer Institute Denver, CO Jay Spiegel, MD Assistant Professor Division of Transplant and Cellular Therapy University of Miami Sylvester Comprehensive Cancer Center Miami, FL In this episode, Dr. Tara Gregory from the Colorado Blood Cancer Institute, and Dr. Jay Spiegel from the Sylvester Comprehensive Cancer Center discuss the evolving role of CAR T-cell therapy in lymphoma and myeloma. They provide a practical overview of CAR-T, including currently approved indications, importance of early referral, patient selection considerations, and strategies for engaging patients in treatment discussions. The conversation also covers key aspects of toxicity management and post-treatment monitoring, while addressing current limitations of CAR-T therapy and future directions that may further expand its role in patient care. Tune in today for this exciting episode! Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients This episode is supported by Bristol Myers Squibb, Johnson & Johnson & Legend Biotech, and Kite, a Gilead Company.

  • June 2 · 38 min

    Optimizing HSCT in Blood Cancers

    Lori Muffly, MD, MS, Stanford Medicine, Stanford, CA Recorded on May 12, 2026 Lori Muffly, MD, MS Professor of Medicine Division of Blood and Marrow Transplantation & Cellular Therapy Stanford Medicine Stanford, CA In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next. Mentioned on this episode: www.NMDP.org www.hematology.org Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

  • May 8 · 35 min

    Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care

    Mayra Allen, PhD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Recorded on April 23, 2026 Mayra Allen, PhD Clinical Psychologist, Psycho-Oncology Service UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, CA Join us for an insightful conversation with Mayra Allen, PhD, clinical psychologist at UCSF’s Helen Diller Family Comprehensive Cancer Center, as we explore actionable strategies for supporting couples, caregivers, and families navigating cancer care. This episode examines practical communication approaches, the evolving role of care partners, and ways to help families manage complex situations. The discussion also addresses important yet often overlooked topics, including changes in intimacy, the impact of cultural perspectives across the cancer journey, and resources to support clinicians in delivering whole person oncology care. Tune in to this thoughtful discussion today! Mentioned on this episode: Caregivers Action Network (CAN) Family Caregiver Alliance Women’s Cancer Resource Center Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

  • April 23 · 34 min

    Driving Progress in AML

    David Sallman, MD, Moffitt Cancer Center, Tampa, FL Recorded on April 9, 2026 David Sallman, MD Associate Member, Department of Malignant Hematology Moffitt Cancer Center Tampa, FL In this exciting episode, Dr. David Sallman from Moffitt Cancer Center takes a deep dive into acute myeloid leukemia (AML) and the advances transforming patient care. The discussion spans newly approved therapies, including menin inhibitors, as well as promising approaches under investigation in clinical trials, and explores how these innovations are influencing treatment selection, transplantation, and the management of side effects and complications in today’s AML landscape. Tune in today for expert insight into what’s shaping the future of AML care. Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients This episode is supported by Kura Oncology, Inc.

  • April 13 · 34 min

    Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment

    Matthew Loscalzo, LCSW, APOS Fellow, City of Hope, Duarte, CA Recorded on March 30, 2026 Matthew Loscalzo, LCSW, APOS Fellow Founding Executive Director and Professor Emeritus of Supportive Care Medicine and Professor of Population Sciences City of Hope Duarte, CA In this episode, licensed clinical social worker Matthew Loscalzo explores how survivors and healthcare professionals […]

  • March 24 · 40 min

    Optimizing Outcomes in Myeloma

    Amy Pierre, MSN, ANP-BC, Flatiron Health and Memorial Sloan Kettering, New York, NY and Peter Voorhees, MD, Levine Cancer Institute, Charlotte, NC Recorded on March 10, 2026 Amy Pierre, MSN, ANP-BC Senior Clinical Director, Research Oncology, Flatiron Health Nurse Practitioner, Memorial Sloan Kettering Cancer Center New York, NY Peter Voorhees, MD Director, Outreach for Hematologic […]

  • March 3 · 39 min

    Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology

    Matthew Kutny, MD, University of Alabama, Birmingham, AL, Julie Guillot, Pediatric AML parent, global advocate, and Blood Cancer United Volunteer, and Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC Recorded on February 19, 2026 Matthew Kutny, MD Professor of Pediatrics Director, Leukemia, Lymphoma and Histiocytosis Program Director, Pediatric Clinical Trials Office Institutional […]

  • February 17 · 39 min

    What’s New and What’s Next in CLL

    Brad Kahl, MD, Siteman Cancer Center, St. Louis MO Recorded on January 27, 2026 Brad Kahl, MD Professor of Medicine Division of Oncology, Department of Medicine Washington University School of Medicine Director, Lymphoma Program Siteman Cancer Center St. Louis, MO In this episode, join Dr. Brad Kahl, Director of the Lymphoma Program at the Siteman […]

  • January 23 · 36 min

    Building Resilience: Burnout & Compassion Fatigue Tools for HCPs

    Building Resilience: Burnout & Compassion Fatigue Tools for HCPs Chelsey Winegar, LCSW, MBA, Intermountain Health, Murray, UT Recorded on January 8, 2026 Chelsey Winegar, LCSW, MBA Manager of Oncology Services Intermountain Health Murray, UT Join Chelsey Winegar, LCSW and Manager of Oncology Services at Intermountain Health in Murray, UT, as she breaks down the key differences […]

  • January 13 · 33 min

    Key Insights from Attending ASH 2025

    Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC Recorded on December 18, 2025 Lore Gruenbaum, PhD Chief Scientific Officer & Senior Vice President of Research Blood Cancer United Washington, DC Join Dr. Lore Gruenbaum, Chief Scientific Officer and Senior Vice President of Research at Blood Cancer United, to provide practice-changing data in hematologic malignancies from […]

  • Dec 17, 2025 · 30 min

    Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know

    Raymond Mailhot, MD, MPH, University of Miami, Miami, FL Recorded on December 2, 2025 Raymond Mailhot, MD, MPH Department of Radiation Oncology University of Miami Miami, FL Join us with Dr. Raymond Mailhot from the University of Miami as we explore how social determinants of health shape patient experiences, treatment decisions, and outcomes. He discusses […]

  • Nov 20, 2025 · 40 min

    Hairy Cell Leukemia: Strategies for Improved Patient Outcomes

    Paul J. Hampel, MD, Mayo Clinic, Rochester, MN Recorded on November 4, 2025 Paul J. Hampel, MD Assistant Professor of Medicine Division of Hematology, Department of Medicine Mayo Clinic Rochester, MN In this episode, Dr. Paul Hampel from Mayo Clinic Rochester takes a comprehensive look at hairy cell leukemia (HCL). He reviews the current diagnostic work-up, […]

  • Nov 6, 2025 · 37 min

    Managing CML: What HCPs Need to Know

    Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on October 23, 2025 Michael J. Mauro, MD Director, Chronic Myeloid Leukemia Program Professor of Medicine, Leukemia Service Memorial Sloan Kettering Cancer Center New York, NY Tune in for this expert-led discussion with Dr. Michael Mauro from Memorial Sloan Kettering Cancer Center […]

Showing 1–20 of 20 episodes